#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	16674	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2025	816.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1384	1384	C	938	C	862	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3550	838.5	0	.	n	.	0	T695C	SNP	695	695	T	1035	1035	C	864	C	809	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3550	838.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1677	1677	A	1010	A	936	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3550	838.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2311	2311	C	915	C,A	848,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3550	838.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2385	2385	A	927	A	862	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	29852	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3550	838.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2937	2937	C	869	C	802	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1942	folP	852	852	100.0	folP.l6.c30.ctg.1	1552	124.6	1	SNP	p	R228S	1	.	.	682	684	AGC	1006	1008	AGC	227;226;225	A;G;C	207;206;203	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5042	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3468	145.0	1	SNP	p	S91F	0	.	.	271	273	TCC	610	612	TCC	170;172;171	T;C;C	155;157;155	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5042	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3468	145.0	1	SNP	p	D95G	0	.	.	283	285	GAC	622	624	GAC	160;158;160	G;A;C	145;142;142	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5042	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3468	145.0	1	SNP	p	D95N	0	.	.	283	285	GAC	622	624	GAC	160;158;160	G;A;C	145;142;142	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1142	mtrR	633	633	97.47	mtrR.l6.c4.ctg.1	1246	91.2	0	.	p	.	0	D79N	NONSYN	235	237	GAT	575	577	AAT	153;152;149	A,G;A;T	141,1;141;136	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1142	mtrR	633	633	97.47	mtrR.l6.c4.ctg.1	1246	91.2	0	.	p	.	0	A86T	NONSYN	256	258	GCG	596	598	ACG	157;164;163	A,G;C,T;G	147,1;150,1;151	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1142	mtrR	633	633	97.47	mtrR.l6.c4.ctg.1	1246	91.2	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	653	655	CAC	184;184;185	C;A;C	164;162;166	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1142	mtrR	633	633	97.47	mtrR.l6.c4.ctg.1	1246	91.2	0	.	p	.	0	S183N	NONSYN	547	549	AGT	887	889	AAT	65;65;64	A;A,G;T	64;64,1;62	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1142	mtrR	633	633	97.47	mtrR.l6.c4.ctg.1	1246	91.2	0	.	p	.	0	M197I	NONSYN	589	591	ATG	929	931	ATA	58;58;62	A;T;A,G	58;58;60,1	.	.
mtrR.WHO_F_01564	mtrR.WHO_F_01564	1	1	539	1142	mtrR	633	633	97.47	mtrR.l6.c4.ctg.1	1246	91.2	1	SNP	p	G45D	0	.	.	133	135	GGC	473	475	GGC	191;191;187	G;G;C	175;176;169	mtrR.WHO_F_01564:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3033	173.2	1	SNP	p	D86N	0	.	.	256	258	GAC	583	585	GAC	201;201;202	G;A;C	185;184;186	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3033	173.2	1	SNP	p	S87R	0	.	.	259	261	AGT	586	588	AGT	201;200;199	A;G;T	185;183;184	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3033	173.2	1	SNP	p	S87I	0	.	.	259	261	AGT	586	588	AGT	201;200;199	A;G;T	185;183;184	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3033	173.2	1	SNP	p	S87W	0	.	.	259	261	AGT	586	588	AGT	201;200;199	A;G;T	185;183;184	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5270	parC	2304	2304	100.0	parC.l15.c30.ctg.1	3033	173.2	1	SNP	p	S88P	0	.	.	262	264	TCC	589	591	TCC	200;202;198	T;C;C	185;188;182	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4254	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2595	163.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1522	1524	GGC	219;219;219	G;G;C	197;198;199	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1240	1242	GCA	213;215;217	G;C,T;A	193;193,1;202	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1243	1245	ATC	219;218;221	A;T;C	204;202;208	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1255	1257	GTG	213;210;209	G;T;G	198;194;195	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1255	1257	GTG	213;210;209	G;T;G	198;194;195	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1759	1761	ACC	211;207;207	A;C;C	189;188;189	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1813	1815	GCG	202;201;199	G;C,T,G;G	184;164,1,1;176	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1813	1815	GCG	202;201;199	G;C,T,G;G	184;164,1,1;176	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1936	1938	GGC	157;155;154	G;G;C	142;145;143	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1945	1947	GGC	145;142;142	G;G;C	133;127;130	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4190	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2273	182.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1963	1965	CCG	127;131;132	C,G;C,G;G	94,5;95,1;99	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5900	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3140	187.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1611	1613	CTG	204;204;206	C;T;G	184;182;188	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2192	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1761	123.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	567	567	C	135	C	119	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1625	184.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	511	513	GTT	261;265;264	G,A;T,G;T	241,1;243,1;243	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1625	184.7	0	.	p	.	0	I75V	NONSYN	223	225	ATT	601	603	GTT	246;245;248	G;T;T	218;208;224	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1625	184.7	0	.	p	.	0	S89T	NONSYN	265	267	AGC	643	645	ACC	261;259;261	A;C;C	222;234;239	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1625	184.7	0	.	p	.	0	I98V	NONSYN	292	294	ATC	670	672	GTC	252;252;247	G;T;C,T	225;222;221,1	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1625	184.7	1	SNP	p	G120K	1	.	.	358	360	AAG	736	738	AAG	255;255;254	A;A;G	237;237;237	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1625	184.7	1	SNP	p	N121D	0	.	.	361	363	AAC	739	741	AAC	251;246;250	A;A;C	234;230;234	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3010	porB1b	1038	1038	99.52	porB1b.l15.c4.ctg.1	1625	184.7	1	SNP	p	A121N	1	.	.	361	363	AAC	739	741	AAC	251;246;250	A;A;C	234;230;234	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12172	rpoB	4179	4179	100.0	rpoB.l15.c30.ctg.1	4892	248.3	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2027	2029	AAT	299;295;290	A;A;T,C	278;274;268,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1308	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1187	109.8	1	SNP	p	V57M	1	.	.	169	171	ATG	570	572	ATG	286;287;284	A;T;G	263;266;261	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
